Durable responses to ATR inhibition with ceralasertib in tumors with genomic defects and high inflammation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Durable responses to ATR inhibition with ceralasertib in tumors with genomic defects and high inflammation

Published:2024-01-16 Issue:2 Volume:134 Page:
ISSN:1558-8238
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:

Author:

Dillon Magnus T.^ORCID,Guevara Jeane,Mohammed Kabir,Patin Emmanuel C.,Smith Simon A.^ORCID,Dean Emma^ORCID,Jones Gemma N.,Willis Sophie E.^ORCID,Petrone Marcella,Silva Carlos,Thway Khin,Bunce Catey^ORCID,Roxanis Ioannis,Nenclares Pablo,Wilkins Anna^ORCID,McLaughlin Martin,Jayme-Laiche Adoracion,Benafif Sarah,Nintos Georgios,Kwatra Vineet,Grove Lorna,Mansfield David^ORCID,Proszek Paula^ORCID,Martin Philip,Moore Luiza,Swales Karen E.^ORCID,Banerji Udai^ORCID,Saunders Mark P.,Spicer James,Forster Martin D.^ORCID,Harrington Kevin J.^ORCID

Funder

Cancer Research UK

NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research

National Institute for Health Research

Rosetrees Trust

AstraZeneca

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://www.jci.org/articles/view/175369/files/pdf

Reference47 articles.

1. Targeting ATR as Cancer Therapy: A new era for synthetic lethality and synergistic combinations?

2. ATR: an essential regulator of genome integrity

3. Targeting ATR in cancer

4. Radiosensitization by the ATR Inhibitor AZD6738 through Generation of Acentric Micronuclei

5. Abstract C60: Pre-clinical efficacy of the ATR inhibitor AZD6738 in combination with the PARP inhibitor olaparib

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Photochemical nitrene transfer reactions of iminoiodinanes with sulfoxides;Green Synthesis and Catalysis;2024-05

2. Targeting ATR Pathway in Solid Tumors: Evidence of Improving Therapeutic Outcomes;International Journal of Molecular Sciences;2024-02-27

3. Targeting ATR in patients with cancer;Nature Reviews Clinical Oncology;2024-02-20

4. Targeting SWI/SNF Complexes in Cancer: Pharmacological Approaches and Implications;Epigenomes;2024-02-04

5. Discovery of the Potent and Selective ATR Inhibitor Camonsertib (RP-3500);Journal of Medicinal Chemistry;2024-02-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3